EXOZYMES INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
EXOZYMES INC. (EXOZ) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 146.44 thousand shares as of 2026-01-14, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-13
- 2026-01-14: Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 146.44K shares.
- 2025-10-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 40.00K shares.
- 2025-07-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 20.00K shares.
- 2025-07-01: Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 235.82K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross |
|---|---|
| 2026-01-14 | 146.44K shares 10-Q · filed 2026-08-13 |
| 2025-10-30 | 40.00K shares 10-Q · filed 2026-08-13 |
| 2025-07-30 | 20.00K shares 10-Q · filed 2026-08-13 |
| 2025-07-01 | 235.82K shares 10-Q · filed 2026-08-13 |
| 2024-05-19 | 5.19K shares 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |